Product image of Meropenem Medical Valley (Meropenem) supplied by GNH India

Meropenem Medical Valley

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Medical Valley (Meropenem)

Meropenem, the active ingredient in Meropenem Medical Valley, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, and meningitis in hospitalized patients.

GNH India supplies Meropenem Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medical Valley Invest Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.
  • Complicated intra‑abdominal infections: provides rapid bacterial eradication and clinical cure.
  • Complicated urinary tract infections: eliminates resistant Gram‑negative pathogens.
  • Hospital‑acquired pneumonia: achieves high lung tissue concentrations for effective treatment.
  • Ventilator‑associated pneumonia: offers coverage against multidrug‑resistant organisms.
  • Meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections.
  • Septicemia: delivers bactericidal activity in bloodstream infections.

How It Works

  • Meropenem binds to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial cell death. Its broad affinity for multiple PBPs gives it activity against a wide range of Gram‑positive and Gram‑negative organisms, including many resistant strains.

Side Effects

Meropenem may cause adverse reactions that vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: may be watery and self‑limiting.
  • Rash: erythematous skin eruption.
  • Injection site pain: discomfort at the IV site.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disorders.
  • Anaphylaxis: acute hypersensitivity reaction requiring immediate treatment.
  • Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.
  • Severe neutropenia: marked reduction in white blood cells increasing infection risk.

Precautions & Warnings

Use meropenem with careful clinical monitoring and consider patient‑specific factors.

  • Renal function: adjust dose in patients with impaired kidney function.
  • Allergy: avoid in individuals with known carbapenem or beta‑lactam hypersensitivity.
  • Seizure risk: monitor closely in patients with a history of seizures or CNS disease.
  • Drug interactions: review concomitant medications that may lower seizure threshold.
  • Pregnancy: prescribe only when benefits outweigh potential risks.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropenem can interact with other medicines, requiring vigilance.

Major Interactions (Avoid)

  • Valproic acid: may increase risk of seizures.
  • Oral contraceptives: carbapenems can reduce hormonal efficacy, risking unintended pregnancy.

Moderate Interactions (Monitor Closely)

  • Probenecid: may raise meropenem plasma concentrations.
  • Loop diuretics: monitor renal function for additive nephrotoxicity.
  • NSAIDs: may affect renal clearance and increase nephrotoxic potential.

Frequently Asked Questions

Meropenem Medical Valley is indicated for severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired and ventilator‑associated pneumonia, meningitis, and septicemia. It is reserved for cases where broad‑spectrum coverage against resistant Gram‑negative and Gram‑positive organisms is required.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, weakening the wall and causing osmotic lysis. Its high affinity for multiple PBPs gives it activity against a wide range of resistant bacteria.

The dosage of Meropenem Medical Valley is determined by the prescribing clinician based on infection type, severity, renal function, and patient weight. The prescriber sets the infusion rate and total daily dose according to established clinical guidelines and individual patient needs.

Safety data for meropenem in pregnancy are limited, and the drug is classified as pregnancy category unknown. It should be used only if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult their physician, as the drug may be excreted in breast milk.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Meropenem offers a broader spectrum against certain resistant Gram‑negative organisms and has a lower risk of seizures compared with imipenem. Both are administered intravenously, but meropenem is often preferred for infections where imipenem‑cilastatin’s renal toxicity is a concern.

Meropenem Medical Valley should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Once reconstituted, use the solution within the time frame specified in the product label and keep it refrigerated if not administered immediately.

The product is supplied as an injectable solution for intravenous infusion. It is typically administered over 15‑30 minutes, depending on the dose and clinical protocol. Administration should be performed by qualified healthcare personnel using aseptic technique.

The most serious risks include seizures, especially in patients with renal impairment or pre‑existing CNS disorders, and severe hypersensitivity reactions such as anaphylaxis. Clinicians should monitor for neurological signs and any signs of allergic response during therapy.

Patients with a documented hypersensitivity to meropenem, other carbapenems, or any beta‑lactam antibiotics should not receive this product. Caution is also advised for individuals with a history of seizures, severe renal impairment, or those taking medications that lower the seizure threshold.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT